Form 8-K - Current report:
SEC Accession No. 0001213900-21-010620
Filing Date
2021-02-19
Accepted
2021-02-19 17:06:42
Documents
7
Period of Report
2021-02-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea135915-8k_citiuspharma.htm 8-K 40797
2 FORM OF INVESTOR WARRANT ISSUED FEBRUARY 19, 2021 ea135915ex4-1_citiuspharma.htm EX-4.1 94980
3 FORM OF PLACEMENT AGENT WARRANT ISSUED FEBRUARY 19, 2021 ea135915ex4-2_citiuspharma.htm EX-4.2 111823
4 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP ea135915ex5-1_citiuspharma.htm EX-5.1 11644
5 FORM OF SECURITIES PURCHASE AGREEMENT, DATED FEBRUARY 16, 2021, BY AND BETWEEN C ea135915ex10-1_citiuspharma.htm EX-10.1 237164
6 PRESS RELEASE OF FEBRUARY 17, 2021 ea135915ex99-1_citiuspharma.htm EX-99.1 8988
7 PRESS RELEASE OF FEBRUARY 19, 2021 ea135915ex99-2_citiuspharma.htm EX-99.2 8805
  Complete submission text file 0001213900-21-010620.txt   515609
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 21656990
SIC: 2834 Pharmaceutical Preparations